Catalyst Wire Dossier Catalyst Wire Dossier

SBI-100 Ophthalmic Emulsion

· Skye Bioscience, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SBI-100 Ophthalmic Emulsion, covering 2026-01-14 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure [Phase 2]

See pricing